StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

NovaBridge Biosciences's total debt was CN¥29.97M at Dec 31, 2023. For fiscal 2023 it was CN¥29.97M, up 58.1% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023CN¥29.97M+58.1%
FY2022Dec 31, 2022CN¥18.96M-62.1%
FY2019Dec 31, 2019CN¥50.00M-37.5%
FY2018Dec 31, 2018CN¥80.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023CN¥29.97M–
Q4 FY2022Dec 31, 2022CN¥18.96M–
Q4 FY2019Dec 31, 2019CN¥50.00M–
Q4 FY2018Dec 31, 2018CN¥80.00M–

More NovaBridge Biosciences figures

See a number that looks wrong?